Please login to the form below
Ligelizumab
This page shows the latest Ligelizumab news and features for those working in and with pharma, biotech and healthcare.
Novartis reveals positive efficacy data for Xolair follow-up
Novartis picked up ligelizumab following its acquisition of UK firm Ziarco in 2016. ... If all goes to plan, Novartis is set to file ligelizumab by the end of 2021.
Latest news
-
Novartis highlights emerging assets and late-stage pipeline at R&D day
Ligelizumab (QGE031), a new treatment for chronic spontaneous urticaria, which has phase 3 results and is due to be filed with regulators by the end of 2021.
-
Novartis adds oral eczema drug with Ziarco acquisition
fevipiprant (QAW039) in phase II and ligelizumab (QGE031) for CIU.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Roche’s Ocrevus boasts positive long-term data in MS
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- Leadership change within Bedrock Group
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Attigo (part of the Mednet Group)
Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
